GlassScriptPhysician profile
Ana M Torres
NPI 1689692923
$3,640.66
in general payments reported to CMS, 2019-2025
17 companies · $257 in 2025
The $257 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $815 · 2020: $708 · 2021: $546 · 2022: $611 · 2023: $611 · 2024: $92.06 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $961.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $960.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $995.08 | 2021-2023 | Avycaz |
| Janssen Pharmaceuticals, INC | $638.62 | 2019-2024 | Xarelto |
| Pfizer INC. | $499.58 | 2019-2025 | |
| Inari Medical, INC. | $420.60 | 2020-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Allergan, INC. | $409.48 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $147.68 | 2025 | Uptravi, Opsumit |
| E.R. Squibb & Sons, L.L.C. | $131.71 | 2020 | |
| Medtronic USA, INC. | $122.55 | 2019 | |
| Novo Nordisk INC | $66.75 | 2019-2022 | |
| Amarin Pharma, INC. | $42.72 | 2019 | |
| Lilly USA, LLC | $32.69 | 2022-2023 | Mounjaro |
| Mallinckrodt Hospital Products INC. | $29.37 | 2024 | Terlivaz |
| Mallinckrodt Enterprises LLC | $24.14 | 2019 | |
| Edwards Lifesciences Corporation | $22.04 | 2025 | |
| Redhill Biopharma INC. | $21.40 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $19.04 | 2024 | |
| Melinta Therapeutics, LLC | $17.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ana Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.